Game Preview

Unit 8 drugs

  •  English    12     Public
    Unit 8 drugs
  •   Study   Slideshow
  • Rationalize the use of mannitol in acute TBI
    reduce ICP by reducing blood viscosity -> increases cerebral blood flow and oxygen transport and constricts pial arterioles -> reduce cerebral blood volume, ICP
  •  15
  • Explain the rationale for the use of fosphenytoin for seizure prophylaxis following TBI
    Anticonvulsant - stabilize neuronal membranes & decrease seizure activity by increase efflux/decrease influx Na+ across cell membrane during generation nerve im
  •  15
  • Identify the MOA of the six different drug therapies used to manage PD symptoms
    COMT inhibitor (Tolcapone)) and MAO-B inhibitor (Selegiline) ->
  •  15
  • Identify a physiologic rationale for the declining efficacy of carbidopa-levodopa treatment over time in PD.
    d
  •  15
  • What is the MOA of the first-line Alzheimer disease treatment
    Donepezil - cholinesterase inhibitor - Boost the amount of ACh in the brain -> higher ACh in synapse, more likely to have a signal -> improve symptoms of dement
  •  15
  • What is the MOA of the second-line Alzheimer disease treatment
    Memantine - NMDA receptor blocker - decreases effects of glutamate (known to cause neuronal toxicity)
  •  15
  • Outline how cannabinoids would alter action potentials to improve MS-related spasticity.
    Cannabinoids decrease the release of pre-synaptic glutamate-> decrease the amplitude of EPSPs-> decrease excitability of motor pathway in CNS ->
  •  15
  • Justify the use of tPA in ischemic stroke
    Alteplase
  •  15
  • Justify the use of diuretics in the treatment of Meniere's disease
    Theoretically improves symptoms by reducing the endolymph volume but high-quality studies on the effect of diuretics are lacking
  •  15
  • Distinguish abortive and preventative pharmacotherapies for migraine headache.
    h
  •  15
  • Identify two subclasses of sedative-hypnotics to treat insomnia. Include MOA
    f
  •  15
  • What is the first-line treatment for anxiety disorders
    g
  •  15